Evidence map›Paper›PMID 38751952›Full record

ArticleBJUI compass2024

Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy.

Ryo Yamashita, Masafumi Nakamura, Akifumi Notsu, Koiku Asakura, Kimitsugu Usui, Yuma Sakura, Hideo Shinsaka, Masato Matsuzaki, Takashi Sugino, Ryuichi Mizuno and 2 more

Erratum issuedAbstract read
In one paragraph

Article in BJUI compass, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Erratum.BJUI compass · 2024
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ryo YamashitaDivision of Urology Shizuoka Cancer Center Shizuoka Japan.ORCID https://orcid.org/0000-0002-4131-1185
Masafumi NakamuraDivision of Urology Shizuoka Cancer Center Shizuoka Japan.
Akifumi NotsuClinical Research Center, Shizuoka Cancer Center Shizuoka Japan.
Koiku AsakuraDivision of Diagnostic Radiology Shizuoka Cancer Center Shizuoka Japan.
Kimitsugu UsuiDivision of Urology Shizuoka Cancer Center Shizuoka Japan.
Yuma SakuraDivision of Urology Shizuoka Cancer Center Shizuoka Japan.
Hideo ShinsakaDivision of Urology Shizuoka Cancer Center Shizuoka Japan.
Masato MatsuzakiDivision of Urology Shizuoka Cancer Center Shizuoka Japan.
Takashi SuginoDivision of Pathology Shizuoka Cancer Center Shizuoka Japan.
Ryuichi MizunoDepartment of Urology Keio University Tokyo Japan.
Masashi NiwakawaDivision of Urology Shizuoka Cancer Center Shizuoka Japan.
Mototsugu OyaDepartment of Urology Keio University Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to evaluate the cumulative incidence of upper tract urothelial carcinoma (UTUC) recurrence and identify its risk factors in patients who underwent radical cystectomy (RC). Patients and methods: We performed RC on 385 patients between September 2002 and February 2020. After excluding 20 patients-13 with simultaneous nephroureterectomy, 6 with distal ureteral stump positivity and 1 with urachal cancer-365 patients were included in the analysis. To predict UTUC recurrence, we examined the cancer extension pattern in cystectomy specimens and categorized them into three types: cancer located only in the bladder (bladder-only type), cancer extending to the urethra or distal ureter (one-extension type) and cancer extending to both the urethra and distal ureter (both-extension type). We determined hazard ratios for UTUC recurrence for each covariate, including this cancer extension pattern. Results: Of the 365 patients, 60% had the bladder-only type, 30% had the one-extension type and 10% had the both-extension type. During a median follow-up period of 72 months for survivors, UTUC recurred in 25 of the 365 patients, with cumulative incidences of 3.7% at 5 years and 8.3% at 10 years. The median interval from cystectomy to recurrence was 65 months (interquartile range: 36-92 months). In the multivariate analysis, the extension pattern was a significant predictor of UTUC recurrence. The hazard ratios for UTUC recurrence were 3.12 (95% confidence interval [CI] = 1.15-8.43, Conclusions: The cancer extension pattern in cystectomy specimens is predictive of UTUC recurrence. A more extensive cancer extension in cystectomy specimens elevates the risk of subsequent UTUC recurrence. Intensive long-term monitoring is essential, particularly for patients with the both-extension type.

Indexed as

bladder cancerclassificationradical cystectomyrecurrenceupper urinary tract

Identifiers

PMID38751952
PMCPMC11090764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.